Clinical Trials Browser

Sarcoma, Alveolar Soft Part × Sunitinib × 90 days × Clear all

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Phase 2 Completed

34 enrolled 22 charts

Sarcoma, Alveolar Soft Part